🇺🇸 FDA
Patent

US 7998684

Screening method for an agent for treatment of neurodegenerative disease

granted A61KA61K38/1709A61P

Quick answer

US patent 7998684 (Screening method for an agent for treatment of neurodegenerative disease) held by Takeda Pharmaceutical Company Limited expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/1709, A61P, A61P25/00, A61P25/16